Here, we demonstrate a major advantage in the analytical range of 0.5–600 µg/mL for THC-A, D9-THC, CBDA, CBD, CBG-A, and CBG and 0.5–100 µg/mL for CBC, CBN, CBD-VA, and CBD-V. This wide analytical range allows for fewer re-dilutions of samples containing what were once considered minor cannabinoids.